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SUMMARY A patient developed ossifying skeletal muscle metastases from a primary gastric mucin-producing adenocarcinoma. The unusual nature of skeletal muscle metastases and the inflammatory-like syndrome associated with heterotopic ossification is reviewed. It is suggested that this case of 'neoplasm-induced post-traumatic myositis ossificans' may be caused by the interaction of local haemorrhage and thrombosis, mucin-producing tumour implants, and the presence of large quantities of gamma-carboxyglutamic acid, an amino acid associated with the calcification of bone matrix formation.
We report the case of a patient in whom ossifying skeletal muscle metastases from an occult gastric carcinoma led to his presentation with a rheumatic illness characterised by back, hip, and shoulder pain. No of the stomach, and a biopsy of the ossified soft tissue mass in the area of the right obturator foramen revealed metastatic carcinoma with adjacent heterotopic ossification (Fig. 2) .
Discussion
Despite the large total mass and extensive blood supply of skeletal muscle, haematogenous metastases rarely develop within it. In one series of 500 autopsies of patients with various metastatic neoplasms only 4 examples of muscle metastases were described. These were associated with rapidly growing anaplastic cancers with numerous metastases in other tissues.4 Not surprisingly, cases in which skeletal muscle metastases were the initial presentation of an occult neoplasm are similarly rare. In the 4 cases reported they presented as isolated enlarging muscle masses.5'7 This striking resistance of skeletal muscle to implantation of haematogenous tumour emboli is not yet understood.
Our patient presented with the painful rheumatic disorder initially characterised by back and bilateral groin pain with radiation into his anterior thighs. A number of diagnoses were initially incorrectly considered. The development of a grossly inflamed shoulder was attributed to myositis ossificans. In addition the exacerbation of pain and stiffness at rest and in the morning, and improvement with activity, were early indications of what seemed an inflammatory illness. Goldberg and Schumacher have previously commented on the close resemblance Malignant myositis ossificans 97 between acute arthritis and periarticular heterotopic ossification.8 These sometimes dramatic symptoms seen both in benign heterotopic ossification and in our case are in contrast to the more bland appearance of nonossifying skeletal muscle metastases, and they suggest that neoplasm-induced heterotopic ossification may instigate apparently an inflammatory rheumatic syndrome.
The cause of neoplasm-induced heterotopic ossification remains unknown; however, we believe several observations are pertinent. Ossification occurs in direct contiguity with neoplasm, suggesting a local rather than a systemic osteogenic effect. Mesenchymal tissue with the ability to differentiate into osteoblasts must be locally available. Most cases of neoplasm-induced heterotopic bone formation have been reported in association with mucin-producing adenocarcinomas.9 Although mucin has not been shown to have any osteogenic capability, it has been demonstrated to be thrombogenic, and the association between mucin-producing adenocarcinomas and venous thrombosis is well-recognised. 10 Recently a relationship has been demonstrated between the coagulation protein prothrombin and the most abundant noncollagenous bone protein osteocalcin. Both proteins are enriched with GLA, an amino acid which is converted from glutamic acid by carboxylation, catalysed by vitamin K. GLA binds calcium with 10 times greater avidity than glutamic acid, making calcium locally available to activate prothrombin and probably to interact with osteocalcin in bone formation."1 Experimental deficiency of vitamin K has been shown to inhibit normal bone formation, presumably owing to lack of formation of GLA.12 We measured the level of GLA in serial 24-hour urine samples before and after treatment of this patient. These levels were elevated initially and fell after treatment (Table 1) . GLA was thus present in large quantities and available for binding calcium both for thrombosis and matrix calcification. 
